Recent clinical studies surrounding this compound, specifically the 120 milligram formulation ZPHC ZPHC, indicate a considerable impact on body mass reduction and linked chronic conditions . Researchers anticipate that this combined compound, influencing both GLP-1 and GIP pathways , could offer a substantial improvement in the management of excess